|
Market Closed -
Toronto S.E.
14:42:35 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 59.06 CAD | +4.03% |
|
+10.28% | - |
| 3 months | +36.14% | ||
| 6 months | +31.75% |
Investment objective
The ETF has been designed to provide investors with exposure to the performance of an index, selected at the discretion of BlackRock, that is composed of companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. The current index for the ETF is the NYSE FactSet Global Genomics and Immuno Biopharma Index.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 158.83USD | +14.36% | +438.59% | 6.58% | |
| 115.07USD | +0.03% | +76.49% | 4.91% | |
| 166.00EUR | +2.09% | +39.50% | 4.67% | |
| 5,813.00JPY | +0.28% | +20.23% | 4.48% | |
| 211.38USD | -0.09% | +165.39% | 4.36% | |
| 49.26EUR | +1.61% | +33.10% | 4.35% | |
| 156.45USD | +3.84% | +48.63% | 4.22% | |
| 1,905.50GBX | +0.79% | +4.44% | 4.18% | |
| 114.05USD | +1.09% | +19.80% | 3.89% | |
In partnership with
| Date | Price | Change |
|---|---|---|
| 26-08-25 | $59.06 | +4.03% |
| 26-08-24 | $56.77 | -0.75% |
| 26-08-21 | $57.20 | +1.92% |
| 26-08-20 | $56.12 | -3.31% |
| 26-08-19 | $58.04 | - |
Other stock markets
Delayed Quote Toronto S.E.
Last update August 25, 2026 at 02:42 pm
Description
| CA46437W1059 | |
|---|---|
| Total Expense Ratio | 0.0044 |
| Asset Class | Stocks |
| Currency | |
| Provider | |
| Underlying | NYSE FactSet Global Genomics and Immuno Biopharma NR Index - CAD |
| Autres ETFs | |
Features and characteristics
| Dividend Policy | Distribution |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Fund Structure | |
| Date of creation |
2022-04-25
|
AuM evolution - 2026-08-11
| AuM (CAD) | 13.2M |
|---|---|
| AuM 1M | 13.2M |
| AuM 3 months | 13.2M |
| AuM 6 months | 13.2M |
| AuM 12 months | 13.2M |
- Stock Market
- ETF
- XDNA ETF
Select your edition
All financial news and data tailored to specific country editions
